Argent Biopharma Limited has released a press release.
Patent Granted for CimetrA
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- Sciensus Rare EU & UK Sales and Distribution Agreement
- Response to ASX Query
- ArtemiC receives Indian importation and sales approval
- ArtemiC Long COVID Syndrome Clinical Study Commenced
- UK Capital Raising Completed
Later from Argent Biopharma
- March 2022 Quarterly Activity and Cash Flow Reports
- Patent Granted for CannEpiL SNEDDS
- Response to ASX Aware Query
- Cognicann Clinical Trial Results
- Glioblastoma pre-clinical trial results
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma